Research Article
Gross Hematuria in Patients with Prostate Cancer: Etiology and Management
Table 1
Characteristics, grade, and etiology of gross hematuria in patients with prostate cancer according to cancer primary treatment.
| Primary treatment | Radical prostatectomy | Other treatments | value |
| Number of patients | 13 | 68 | | Mean age (SD) | 65.5 (8.46) | 74.3 (7.1) | 0.003 | Median PSA (ng/mL) | 7.4 | 18.5 | 0.02 | Median Gleason score | 7 | 7 | | Hematuria | | | | Grade II | 5 (38.5%) | 37 (54.4%) | | Grades III∖IV | 8 (61.5%) | 31 (45.6%) | 0.369 | Etiology of hematuria | | | | Prostatic bleeding | — | 44 (64.7%) | | Prostate cancer | — | 41 (60.3%) | | Benign disease | — | 3 (5.4%) | | Bladder cancer | 5 (38.5%) | 4 (5.9%) | | Infection | 3 (23.1%) | 9 (13.2%) | | Urolithiasis | 1 (7.7%) | 1 (1.5%) | | Suture | 2 (15.4%) | — | | Radiation cystitis | — | 9 (13.2%) | | No diagnosis | 1 (7.7%) | — | | DIC | 1 (7.7%) | 1 (1.5%) | |
|
|